Treatment and outcomes of community-acquired pneumonia at Canadian hospitals

CMAJ. Canadian Medical Association Journal

Volumn 162, Issue 10, 2000, Pages 1415-1420

  Feagan, Brian G ^a,d   Marrie, Thomas J ^a   Lau, Catherine Y ^a,b   Wheeler, Susan L ^c   Wong, Cindy J ^a   Vandervoort, Margaret K ^a,b  

^a Queen's Cancer Research Institute   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

^c Janssen Ortho Inc   (Canada)

^d ROBARTS RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; CANADA; CLINICAL PRACTICE; CLINICAL PROTOCOL; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HUMAN; INTENSIVE CARE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; PNEUMONIA; TREATMENT OUTCOME;

EID: 0034673958     PISSN: 08203946     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Bardett JG, Mundy LAI. Community-acquired pneumonia. N Engl J Med 1995;333(24):16I8-24.
2. Neiderman AIS, AlcCombs J, linger A, Kumar A, Popovian R. The cost of treating community-acquired pneumonia. Clin Tber 1998;20(4):820-36.
3. Guest JF, Morris A. Community-acquired pneumonia: the annual cost to the National Health Service in the UK. EnrRespirJ 1997;IO:1530-4.
4. Cleary P, Greenfield S, Mulley A, Pauker SG, Schrocder SA, Wexler L, et al. Variations in length of stay and outcomes for six medical and surgical conditions in Massachusetts and California.y^lAW 1991;266:73-9.
5. McCormick D, Fine MJ, Coley CM, Marrie TJ, Lave JR, Obrosky DS, et al. Variation in length of hospital stay in patients with community-acquired pneumonia: Are shorter stays associated with worse medical outcomes? Am J AW1999;107:5-12.
6. Fine MJ, Singer DE, Phelps AL, Hanusa BH, Kapoor WN. Differences in length of hospital stay in patients with community-acquired pneumonia: a prospective four-hospital study. Med Care 1993;31:371-80.
7. Fine AI, Hough L, Medsger A, Li YH, Ricci E, Singer D, et al. The hospital admission decision for patients with community-acquired pneumonia. Arch Intern Med 1997;\57:16-U.
8. International classification of diseases, 9tb revision (clinical modification). Los Angeles: Practice Alanagement Information Corporation; 1995.
9. Fine MJ, Auble TE, Yealy DAI, Hanusa BH, Weissfeld LA, Singer DE, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. NEnglJMed 1997;336(4):243-50.
10. Bartlett JG, Breiman RF, AlandeM LA, File TM Jr. Community-acquired pneumonia in adults: guidelines for management. The Infectious Diseases Society of America. Clin Infect Dis 1998;26:811-38.
11. Snedecor G\V, Cochran WG. Statistical methods. 8th éd. Ames (IA): Iowa State University Press; 1989.
12. Adas SJ, Benzer TI, Borowsky LH, Chang Y, Bumham DC, Metlay JP, et al. Safely increasing the proportion of patients with community-acquired pneumonia treated as outpatients: an interventional trial. Arch Intern filed 1998; 158:1350-6.
13. Gilbert K, Gleason PP, Singer DE, Alarrie TJ, Coley CM, Obrosky DS, et al. Variations in antimicrobial use and cost in more than 2000 patients with community-acquired pneumonia. ArnJMed 1998; 104:17-2 7.
14. Weingarten SR, Riedinger A1S, Varis G, Noah AIS, Belman AIJ, Aleyer RD, et al. Identification of low-risk hospitalized patients with pneumonia. Implications for early conversion to oral antimicrobial therapy. Chest 1994;105:1109-15.
15. Alarrie TJ, Lau CY, Wheeler SL, Wong CJ, Vandervoort AIK, Feagan EG. A controlled trial of a critical pathway for treatment of community-acquired pneumonia. CAPITAL Study Investigators. Community-Acquired Pneumonia Intervention Trial Assessing Levofloxacin.y/OW 2000;283:749-55.
16. Fine AIJ, Aledsger AR, Stone RA, Alarrie TJ, Coley CM, Singer DE, et al. The hospital discharge decision for patients with community-acquired pneumonia. Results from the Pneumonia Patient Outcomes Research Team Cohort Study. Arch Intern Med 1997;157:47-56.
17. Alarras TK, Chan CK. Use of guidelines in treating community-acquired pneumonia. Chest 1998;113(6):1689-94.